1. Home
  2. ATAI vs ATGL Comparison

ATAI vs ATGL Comparison

Compare ATAI & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • ATGL
  • Stock Information
  • Founded
  • ATAI 2018
  • ATGL 2017
  • Country
  • ATAI Germany
  • ATGL Hong Kong
  • Employees
  • ATAI N/A
  • ATGL N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • ATGL
  • Sector
  • ATAI Health Care
  • ATGL
  • Exchange
  • ATAI Nasdaq
  • ATGL Nasdaq
  • Market Cap
  • ATAI 282.6M
  • ATGL 409.9M
  • IPO Year
  • ATAI 2021
  • ATGL 2023
  • Fundamental
  • Price
  • ATAI $1.41
  • ATGL $26.63
  • Analyst Decision
  • ATAI Strong Buy
  • ATGL
  • Analyst Count
  • ATAI 3
  • ATGL 0
  • Target Price
  • ATAI $10.50
  • ATGL N/A
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • ATGL 7.9K
  • Earning Date
  • ATAI 05-19-2025
  • ATGL 12-31-2024
  • Dividend Yield
  • ATAI N/A
  • ATGL N/A
  • EPS Growth
  • ATAI N/A
  • ATGL N/A
  • EPS
  • ATAI N/A
  • ATGL N/A
  • Revenue
  • ATAI $308,000.00
  • ATGL $1,590,148.00
  • Revenue This Year
  • ATAI $65.58
  • ATGL N/A
  • Revenue Next Year
  • ATAI N/A
  • ATGL N/A
  • P/E Ratio
  • ATAI N/A
  • ATGL N/A
  • Revenue Growth
  • ATAI N/A
  • ATGL 42.17
  • 52 Week Low
  • ATAI $1.03
  • ATGL $1.15
  • 52 Week High
  • ATAI $2.57
  • ATGL $57.32
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • ATGL 46.71
  • Support Level
  • ATAI $1.36
  • ATGL $25.57
  • Resistance Level
  • ATAI $1.54
  • ATGL $26.19
  • Average True Range (ATR)
  • ATAI 0.09
  • ATGL 1.31
  • MACD
  • ATAI -0.00
  • ATGL -0.24
  • Stochastic Oscillator
  • ATAI 0.00
  • ATGL 26.29

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

Share on Social Networks: